{
    "eid": "2-s2.0-84896445791",
    "title": "Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Transplantation",
            "@code": "2747"
        },
        {
            "$": "Surgery",
            "@code": "2746"
        }
    ],
    "keywords": [],
    "authors": [
        "A. Wanitchanont"
    ],
    "citedby-count": 7,
    "ref-count": 8,
    "ref-list": [
        "The Banff 97 working classification of renal allograft pathology",
        "The Natural History of Chronic Allograft Nephropathy",
        "Everolimus (certican) 12-month safety and efficacy versus mycophenolate mofetil in de Novo renal transplant recipients",
        "Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies",
        "Effect of sirolimus on the metabolism of apoB100-containing lipoproteins in renal transplant patients",
        "Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus",
        "Population pharmacokinetics of everolimus in de novo renal transplant patients: Impact of ethnicity and comedications",
        "Longtitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}